Facharzt FMH Medizinische Onkologie
Facharzt FMH Medizinische Onkologie (Switzerland)
Quick practiceEnglish
Exam overviewPractice session
A 56-year-old postmenopausal woman undergoes breast-conserving surgery and sentinel lymph node biopsy for an invasive ductal carcinoma of the breast. Pathology reveals a 2.2 cm, grade 2 tumor with 2 positive sentinel lymph nodes (pT2 pN1a M0). The tumor is estrogen receptor (ER) 95% positive, progesterone receptor (PR) 80% positive, and HER2-negative (IHC 1+). A 21-gene recurrence score (Oncotype DX) assay returns a recurrence score of 28. According to ESMO guidelines and landmark clinical trial data, what is the most appropriate systemic adjuvant treatment strategy?
Loading your practice session…